JP2024539273A5 - - Google Patents

Info

Publication number
JP2024539273A5
JP2024539273A5 JP2024524598A JP2024524598A JP2024539273A5 JP 2024539273 A5 JP2024539273 A5 JP 2024539273A5 JP 2024524598 A JP2024524598 A JP 2024524598A JP 2024524598 A JP2024524598 A JP 2024524598A JP 2024539273 A5 JP2024539273 A5 JP 2024539273A5
Authority
JP
Japan
Prior art keywords
cells
tcr
polypeptide
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024524598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024539273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/078597 external-priority patent/WO2023076863A2/en
Publication of JP2024539273A publication Critical patent/JP2024539273A/ja
Publication of JP2024539273A5 publication Critical patent/JP2024539273A5/ja
Pending legal-status Critical Current

Links

JP2024524598A 2021-10-25 2022-10-24 Ｍａｇｅ－ａ４抗原を標的とするペプチドおよび操作されたｔ細胞受容体ならびに使用の方法 Pending JP2024539273A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163271368P 2021-10-25 2021-10-25
US63/271,368 2021-10-25
US202163279527P 2021-11-15 2021-11-15
US63/279,527 2021-11-15
PCT/US2022/078597 WO2023076863A2 (en) 2021-10-25 2022-10-24 Peptides and engineered t cell receptors targeting mage-a4 antigen and methods of use

Publications (2)

Publication Number Publication Date
JP2024539273A JP2024539273A (ja) 2024-10-28
JP2024539273A5 true JP2024539273A5 (enExample) 2025-10-31

Family

ID=86158936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024524598A Pending JP2024539273A (ja) 2021-10-25 2022-10-24 Ｍａｇｅ－ａ４抗原を標的とするペプチドおよび操作されたｔ細胞受容体ならびに使用の方法

Country Status (4)

Country Link
EP (1) EP4422651A4 (enExample)
JP (1) JP2024539273A (enExample)
CA (1) CA3236237A1 (enExample)
WO (1) WO2023076863A2 (enExample)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3440106T3 (da) * 2016-04-08 2021-10-04 Adaptimmune Ltd T-cellereceptorer
US20210147550A1 (en) * 2017-08-18 2021-05-20 Joshua Michael Francis Antigen-binding proteins targeting shared antigens
EP3731876A4 (en) * 2017-12-28 2022-04-06 Gritstone bio, Inc. ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS
PH12021553152A1 (en) * 2019-06-18 2022-08-15 Regeneron Pharma Mage-a4 t cell receptors and methods of use thereof
AU2021276264A1 (en) * 2020-05-18 2022-12-22 Board Of Regents, The University Of Texas System Engineered T cell receptors and methods of use

Similar Documents

Publication Publication Date Title
US12116604B2 (en) Transposase polypeptides and uses thereof
WO2017066760A1 (en) Compositions and methods for inhibition of lineage specific antigens
JP2023528255A5 (enExample)
AU2020206359A1 (en) Modified cell expansion and uses thereof
JP2023548556A5 (enExample)
CN110511912A (zh) 免疫细胞的功能调节
KR20210132668A (ko) 인공 면역감시 키메라 항원 수용체(ai-car) 및 이를 발현하는 세포
JP2025527657A (ja) Ｎｙ－ｅｓｏ－１特異的ｔ細胞受容体とキメラ共刺激受容体との組み合わせ物
CN111040036A (zh) 抗gpc3单克隆抗体、由其修饰的免疫效应细胞及其应用
CN109641032A (zh) 用于治疗黑素瘤的方法和组合物
JP2024539273A5 (enExample)
CN102898508B (zh) 封闭TGF-β受体或IL-10受体的多肽、其药物组合物及其用途
CN113929767B (zh) 具有高亲和力的t细胞受体及其用途
CN117924519A (zh) 靶向cd138的嵌合抗原受体
Lucansky et al. DNA vaccination against bcr-abl-positive cells in mice
JP2023530245A5 (enExample)
CN110016074A (zh) Mage-a3人源化t细胞受体
CN113321743A (zh) 一种靶向赖氨酰氧化酶1的嵌合抗原受体及其用途
JP2024526836A5 (enExample)
CN118574843A (zh) 以可检测的亲和力结合特异性肽的抗原识别构建体和对kras具有抗原特异性的t细胞受体以及相应的核酸序列、载体、宿主细胞、药物组合物和试剂盒
WO2024243807A1 (zh) 靶向ny-eso-1的高亲和力t细胞受体及其应用
WO2023091910A1 (en) Methods for cancer immunotherapy
HK40056224A (en) Transposase polypeptides and uses thereof
CN119751694A (zh) 一种靶向cd3l1的特异性嵌合抗原受体、免疫细胞及其应用
CN115368471A (zh) 靶向间皮素的嵌合受体及其用途